Stem cells in gastrointestinal cancers: A matter of choice in cell fate determination

Expert Review of Anticancer Therapy

Volumn 10, Issue 10, 2010, Pages 1621-1633

  Wei, Bo ^a   Chen, Lin ^a   Li, Rong ^a   Tian, Jiahe ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

cancer stem cells; metastasis; niche; stem cell signaling; targeted therapies; tumor growth

Indexed keywords

BONE MORPHOGENETIC PROTEIN; NOTCH RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

CANCER STEM CELL; CARCINOGENESIS; CELL ACTIVATION; CELL FATE; CELL TRANSFORMATION; HUMAN; INTESTINE CANCER; INTESTINE EPITHELIUM; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH EPITHELIUM;

CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INTESTINAL MUCOSA; MALE; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 77958047554     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.10.52     Document Type: Review

References (88)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J. Clin. 59(4), 225-249 (2009).
2. Gupta PB, Chaffer CL, Weinberg RA. Cancer stem cells: mirage or reality? Nat. Med. 15(9), 1010-1012 (2009).
3. Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367(6464), 645-648 (1994).
4. Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 432, 396-401 (2004).
5. Prince ME, Sivanandan R, Kaczorowski A et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl Acad. Sci. USA 104(3), 973-978 (2007).
6. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123), 106-110 (2007).
7. Vermeulen L, Todaro M, de Sousa Mello F et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc. Natl Acad. Sci. USA 105(36), 13427-13432 (2008).
8. Shervington A, Lu C. Expression of multidrug resistance genes in normal and cancer stem cells. Cancer Invest. 26(5), 535-542 (2008).
9. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res. 66(4), 1883-1890 (2006).
10. Smith GH, Chepko G. Mammary epithelial stem cells. Microsc. Res. Tech. 52(2), 190-203 (2001).
11. Jamieson CH, Ailles LE, Dylla SJ et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351(7), 657-667 (2004).
12. Houghton J, Morozov A, Smirnova I, Wang TC. Stem cells and cancer. Semin. Cancer Biol. 17(3), 191-203 (2007).
13. Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 66(9), 4553-4557 (2006).
14. Yen TH, Wright NA. The gastrointestinal tract stem cell niche. Stem Cell Rev. 2(3), 203-212 (2006).
15. Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 307(5717), 1904-1909 (2005).
16. Moore KA, Lemischka IR. Stem cells and their niches. Science 311(5769), 1880-1885 (2006).
17. Potten CS, Kovacs L, Hamilton E. Continuous labelling studies on mouse skin and intestine. Cell Tissue Kinet. 7(3), 271-283 (1974).
18. Potten CS. Extreme sensitivity of some intestinal crypt cells to X and g irradiation. Nature 269(5628), 518-521 (1977).
19. Marshman E, Booth C, Potten CS. The intestinal epithelial stem cell. Bioessays 24(1), 91-98 (2002).
20. Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell. Am. J. Anat. 141(4), 461-479 (1974).
21. Bjerknes M, Cheng H. Clonal analysis of mouse intestinal epithelial progenitors. Gastroenterology 116(1), 7-14 (1999).
22. Barker N, van Es JH, Kuipers J et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449(7165), 1003-1007 (2007).
23. Kitayama Y, Nakamura S, Sugimura H, Kino I. Cytophotometric and flow cytometric DNA content of isolated glands in gastric neoplasia. Gut 36(4), 516-521 (1995).
24. Leedham SJ, Thliveris AT, Halberg RB et al. Gastrointestinal stem cells and cancer: bridging the molecular gap. Stem Cell Rev. 1(3), 233-241 (2005).
25. Mills JC, Andersson N, Hong CV et al. Molecular characterization of mouse gastric epithelial progenitor cells. Proc. Natl Acad. Sci. USA 99(23), 14819-14824 (2002).
26. Bjerknes M, Cheng H. Multipotential stem cells in adult mouse gastric epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 283(3), G767-G777 (2002).
27. Mishra L, Shetty K, Tang Y et al. The role of TGF-b and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene 24(37), 5775-5789 (2005). (Pubitemid 43086137)
28. Kayahara T, Sawada M, Takaishi S et al. Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett. 535(1-3), 131-135 (2003).
29. Barker N, Ridgway RA, van Es JH et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457(7229), 608-611 (2009).
30. Barker N, Huch M, Kujala P et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6(1), 25-36 (2010).
31. Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 40(7), 915-920 (2008).
32. Zhu L, Gibson P, Currle DS et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457(7229), 603-607 (2009).
33. van der Flier LG, Haegebarth A, Stange DE et al. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 137(1), 15-17 (2009).
34. He XC, Yin T, Grindley JC et al. PTENdeficient intestinal stem cells initiate intestinal polyposis. Nat. Genet. 39(2), 189-198 (2007).
35. May R, Sureban SM, Hoang N et al. Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-proteincoupled receptor mark quiescent and cycling intestinal stem cells, respectively. Stem Cells 27(10), 2571-2579 (2009).
36. Gregorieff A, Pinto D, Begthel H et al. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 129(2), 626-638 (2005).
37. Demidov ON, Timofeev O, Lwin HN et al. Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine. Cell Stem Cell 1(2), 180-190 (2007).
38. Seigel GM, Hackam AS, Ganguly A et al. Human embryonic and neuronal stem cell markers in retinoblastoma. Mol. Vis. 13, 823-832 (2007).
39. Trichopoulos D, Lagiou P, Adami HO. Towards an integrated model for breast cancer etiology: the crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res. 7(1), 13-17 (2005).
40. Groen EJ, Roos A, Muntinghe FL et al. Extra-intestinal manifestations of familial adenomatous polyposis. Ann. Surg. Oncol. 5(9), 2439-2450 (2008).
41. Boman BM, Huang E. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. J. Clin. Oncol. 26(17), 2828-2838 (2008).
42. Takaishi S, Okumura T, Tu S et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27(5), 1006-1020 (2009).
43. Taylor RW, Barron MJ, Borthwick GM et al. Mitochondrial DNA mutations in human colonic crypt stem cells. J. Clin. Invest. 112(9), 1351-1360 (2003).
44. Calabrese P, Tavare S, Shibata D. Pretumor progression: clonal evolution of human stem cell populations. Am. J. Pathol. 164(4), 1337-1346 (2004).
45. Park HS, Goodlad RA, Wright NA. Crypt fission in the small intestine and colon. A mechanism for the emergence of G6PD locus-mutated crypts after treatment with mutagens. Am. J. Pathol. 147(5), 1416-1427 (1995).
46. Greaves LC, Preston SL, Tadrous PJ et al. Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc. Natl Acad. Sci. USA 103(3), 714-719 (2006).
47. Shih IM, Wang TL, Traverso G et al. Top-down morphogenesis of colorectal tumors. Proc. Natl Acad. Sci. USA 98(5), 2640-2645 (2001).
48. Preston SL, Wong WM, Chan AO et al. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res. 63(13), 3819-3825 (2003).
49. Nakamura S, Kino I. Morphogenesis of minute adenomas in familial polyposis coli. J. Natl Cancer Inst. 73(1), 41-49 (1984).
50. Li L, Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 327(5965), 542-545 (2010).
51. Dreesen O, Brivanlou AH. Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev. 3(1), 7-17 (2007).
52. Smith K, Bui TD, Poulsom R et al. Up-regulation of macrophage Wnt gene expression in adenoma-carcinoma progression of human colorectal cancer. Br. J. Cancer 81(3), 496-502 (1999).
53. Kim BM, Mao J, Taketo MM et al. Phases of canonical Wnt signaling during the development of mouse intestinal epithelium. Gastroenterology 133(2), 529-538 (2007).
54. Korinek V, Barker N, Moerer P et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19(4), 379-383 (1998).
55. Leedham SJ, Wright NA. Expansion of a mutated clone: from stem cell to tumour. J. Clin. Pathol. 61(2), 164-171 (2008).
56. Shibata H, Toyama K, Shioya H et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278(5335), 120-123 (1997).
57. Sansom OJ, Reed KR, Hayes AJ et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 18(12), 1385-1390 (2004).
58. Schneikert J, Grohmann A, Behrens J. Truncated APC regulates the transcriptional activity of b-catenin in a cell cycle dependent manner. Hum. Mol. Genet. 16(2), 199-209 (2007).
59. Park WS, Oh RR, Park JY et al. Frequent somatic mutations of the b-catenin gene in intestinal-type gastric cancer. Cancer Res. 59(17), 4257-4260 (1999).
60. Ebert MP, Fei G, Kahmann S et al. Increased b-catenin mRNA levels and mutational alterations of the APC and b-catenin gene are present in intestinaltype gastric cancer. Carcinogenesis 23(1), 87-91 (2002).
61. Firestein R, Bass AJ, Kim SY et al. CDK8 is a colorectal cancer oncogene that regulates b-catenin activity. Nature 455(7212), 547-551 (2008).
62. Haramis AP, Begthel H, van den Born M et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303(5664), 1684-1686 (2004).
63. Hardwick JC, Kodach LL, Offerhaus GJ et al. Bone morphogenetic protein signaling in colorectal cancer. Nat. Rev. Cancer 8(10), 806-812 (2008).
64. Brabletz S, Schmalhofer O, Brabletz T. Gastrointestinal stem cells in development and cancer. J. Pathol. 217(2), 307-317 (2008).
65. Kopan R. Notch: a membrane-bound transcription factor. J. Cell Sci. 115(Pt 6), 1095-1097 (2002).
66. Sander GR, Powell BC. Expression of notch receptors and ligands in the adult gut. J. Histochem. Cytochem. 52, 509-516 (2004).
67. Jensen J, Pedersen EE, Galante P et al. Control of endodermal endocrine development by Hes-1. Nat. Genet. 24(1), 36-44 (2000).
68. López-Díaz L, Jain RN, Keeley TM et al. Intestinal neurogenin 3 directs differentiation of a bipotential secretory progenitor to endocrine cell rather than goblet cell fate. Dev. Biol. 309(2), 298-305 (2007).
69. Naya FJ, Huang HP, Qiu Y et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev. 11(18), 2323-2334 (1997).
70. Fleisher AS, Raman R, Siemers ER et al. Phase 2 safety trial targeting amyloid b production with a g-secretase inhibitor in Alzheimer disease. Arch. Neurol. 65(8), 1031-1038 (2008).
71. Milano J, McKay J, Dagenais C et al. Modulation of notch processing by g-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol. Sci. 82(1), 341-358 (2004).
72. Mishra L, Derynck R, Mishra B. Transforming growth factor-b signaling in stem cells and cancer. Science 310(5745), 68-71 (2005).
73. Veenendaal LM, Kranenburg O, Smakman N et al. Differential Notch and TGFb signaling in primary colorectal tumors and their corresponding metastases. Cell Oncol. 30(1), 1-11 (2008).
74. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectaltumor development. N. Engl. J. Med. 319(9), 525-532 (1988).
75. Zhou S, Buckhaults P, Zawel L et al. Targeted deletion of Smad4 shows it is required for transforming growth factor b and activin signaling in colorectal cancer cells. Proc. Natl Acad. Sci. USA 95(5), 2412-2416 (1998).
76. Markowitz S, Wang J, Myeroff L et al. Inactivation of the type II TGF-b receptor in colon cancer cells with microsatellite instability. Science 268(5215), 1336-1338 (1995).
77. Taketo MM, Takaku K. Gastro-intestinal tumorigenesis in Smad4 mutant mice. Cytokine Growth Factor Rev. 11(1-2), 147-157 (2000).
78. Roberts AB, Tian F, Byfield SD et al. Smad3 is key to TGF-b-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev. 17(1-2), 19-27 (2006).
79. Tang Y, Katuri V, Srinivasan R et al. Transforming growth factor-b suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. Cancer Res. 65(10), 4228-4237 (2005).
80. Dong YF, Soung do Y, Chang Y et al. Transforming growth factor-b and Wnt signals regulate chondrocyte differentiation through Twist1 in a stage-specific manner. Mol. Endocrinol. 21(11), 2805-2820 (2007).
81. Labbe E, Lock L, Letamendia A et al. Transcriptional cooperation between the transforming growth factor-b and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res. 67(1), 75-84 (2007).
82. Edlund S, Lee SY, Grimsby S et al. Interaction between Smad7 and b-catenin: importance for transforming growth factor b-induced apoptosis. Mol. Cell Biol. 25(4), 1475-1488 (2005).
83. Fukaya M, Isohata N, Ohta H et al. Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. Gastroenterology 131(1), 14-29 (2006).
84. Takashima S, Mkrtchyan M, Younossi-Hartenstein A et al. The behaviour of Drosophila adult hindgut stem cells is controlled by Wnt and Hh signalling. Nature 454(7204), 651-655 (2008).
85. Sell S. Cancer and stem cell signaling: a guide to preventive and therapeutic strategies for cancer stem cells. Stem Cell Rev. 3(1), 1-6 (2007).
86. Vandrovcova J, Lagerstedt-Robinsson K, Pahlman L et al. Somatic BRAF-V600E mutations in familial colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 15(11), 2270-2273 (2006).
87. Bonhomme C, Calon A, Martin E et al. Cdx1, a dispensable homeobox gene for gut development with limited effect in intestinal cancer. Oncogene 27(32), 4497-4502 (2008).
88. Lickert H, Domon C, Huls G et al. Wnt/(b)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine. Development 127(17), 3805-3813 (2000).